查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1852786

復甦設備市場（按設備類型、應用程式、最終用戶和銷售管道）——全球預測，2025-2032年

Resuscitation Devices Market by Device Type, Application, End User, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，復甦設備市場規模將達到 116.9 億美元，複合年成長率為 5.59%。

關鍵市場統計數據
基準年 2024 75.6億美元
預計年份：2025年 79.8億美元
預測年份 2032 116.9億美元
複合年成長率 (%) 5.59%

簡明扼要地闡述了技術、臨床需求和商業化這三者之間的策略交匯點，以此定義現代復甦的優先事項。

本執行摘要概述了影響技術創新、應用和採購的策略因素。科技的快速發展、對院外照護日益成長的關注，以及在臨床和家庭環境中不斷擴展的應用場景，都提升了去心房顫動、植入式裝置和穿戴式療法的知名度和戰略重要性。在此背景下，從產品開發到醫院採購的相關人員必須兼顧臨床療效、監管路徑、報銷複雜性和分銷動態，才能保持競爭力。

這一領域的特徵是產品迭代速度加快、與數位健康平台緊密整合，以及更重視以使用者為中心的設計，以支援非臨床急救人員。同時，與電子健康記錄和遠端檢測系統的互通性正逐漸成為一項基本要求，而非差異化優勢。在此背景下，決策者必須明確臨床需求、監管限制和商業機會的交會點。本導言概述了新興趨勢、關稅相關影響、市場區隔洞察、區域發展、競爭動態和建議措施，為後續章節奠定了基礎，並為復甦醫療設備領域的領導者提供了一套實用的行動指南。

小型化、互聯互通和不斷變化的醫療環境的融合如何重新定義復甦設備的產品設計重點和競爭優勢？

復甦設備領域正經歷變革時期的驅動力來自於技術創新、醫療環境的擴展以及臨床通訊協定的演變。首先，小型化和更高的能源效率使得更便攜、更易於使用的外部設備成為可能。同時，導線設計和電池化學的創新延長了植入式系統的使用壽命並提高了其可靠性。此外，心律不整檢測和自適應起搏邏輯的演算法進步提高了臨床診斷的準確性，減少了不必要的干涉，並增強了患者的安全性。

其次，醫療服務範圍從三級醫院擴展到門診中心、居家照護機構和社區公共場所，再形成了產品需求。復甦解決方案如今必須在臨床級性能、易用性、遠端監控功能和經濟高效的維護之間取得平衡。雲端事件報告、遠距離診斷和裝置管理平台對於生命週期支援和上市後監管至關重要。最後，監管機構日益關注網路安全、軟體檢驗和實際效能數據，這些都需要工程、臨床和監管團隊之間的跨職能協作。因此，能夠整合臨床證據產生、數位化服務和靈活上市模式的公司將獲得永續的競爭優勢。

受關稅干預措施的影響，策略供應鏈重組和採購策略調整正在改變，這些措施重塑了成本結構和籌資策略。

美國關稅於2025年實施，由此引發了一系列成本和供應鏈動態動態，要求製造商、經銷商和醫療系統進行策略調整。關稅導致投入成本上升，使得籌資策略受到更嚴格的審查，促使各機構重新評估供應商關係、近岸外包方案以及在控制成本的同時維持臨床性能的組件級替代方案。為此，一些製造商加快了對替代供應商的資格認證，優先考慮可實現在地採購的模組化設計，並加強了談判，最終達成了更長期的採購協議和供應保證。

除了對成本的直接影響外，關稅還影響了庫存計劃和前置作業時間管理，迫使採購團隊採用更複雜的需求預測技術和安全庫存策略。這種轉變促使銷售和營運團隊加強協作，以使合約條款與生產實際情況相符，並在可能的情況下實施更靈活的生產能力。此外，關稅也使捆綁式維護、延長保固和遠端監控等附加價值服務更具吸引力，從而抵消了價格敏感度並維持了淨利率。展望未來，建立具有彈性的供應鏈和透明的成本溝通對於維持市場進入和支持長期臨床應用至關重要。

全面的細分分析揭示了產品類型、臨床用途、終端用戶環境和銷售管道如何影響產品策略和商業性執行。

了解市場區隔的細微差別，有助於我們了解每種設備類型、臨床應用、最終用戶和銷售管道的獨特發展路徑和商業化策略。按裝置類型分類，競爭格局包括自動體外心臟去顫去心房顫動 ( AED)、植入式心臟整流去顫器) 、手動體外去心房顫動去心房顫動) 和穿戴式式去心房顫動。在這一格局中，AED 又可細分為全自動和半自動； 植入式心臟整流去顫器包括雙心室、雙側心室和單心室； 去心房顫動則分為攜帶式和固定式。這些差異會影響產品設計重點、監管證據需求和上市後支援模式，其中植入式技術需要長期臨床數據，而體外設備則更注重易用性和維護性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧驅動的預測分析技術整合到自動體外去顫器（AED）中，以便在心臟病發作前進行檢測。
  • 攜帶式體外膜氧合技術在現場復甦支持的進展
  • 在緊急情況下，無需電池的動能術輔助設備的使用率正在上升。
  • 雲端連接去心房顫動集群的出現，實現了集中式性能分析​​和維護警報
  • 將即時遠端醫療連接整合到自動化復甦單元中，以支援遠距臨床教學

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依設備類型分類的復甦設備市場

  • 自動體外心臟去心房顫動
    • 全自動
    • 半自動
  • 植入式心臟整流去顫器
    • 雙心室
    • 兩個腔室
    • 單腔
  • 手動體外去心房顫動
    • 可攜式的
    • 固定式
  • 去心房顫動

第9章 按應用分類的復甦設備市場

  • 心臟麻痹
    • 心臟起搏
    • 心臟復律
    • 去心房顫動
  • 呼吸衰竭
    • 侵入性通氣
    • 人工復甦
    • 非侵入性通氣

第10章 按最終用戶分類的復甦設備市場

  • 門診治療中心
  • 緊急醫療服務
  • 居家照護
  • 醫院
  • 專科診所

第11章 復甦設備市場（依銷售管道分類）

  • 直銷
  • 經銷商
  • 線上銷售

第12章 各地區復甦設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 按組別分類的復甦設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國復甦設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Koninklijke Philips NV
    • Medtronic plc
    • ZOLL Medical Corporation
    • Nihon Kohden Corporation
    • Dragerwerk AG & Co. KGaA
    • Ambu A/S
    • Becton, Dickinson and Company
    • Teleflex Incorporated
    • Smiths Group plc
    • Mindray Medical International Limited
Product Code: MRR-3D2FD205BF84

The Resuscitation Devices Market is projected to grow by USD 11.69 billion at a CAGR of 5.59% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.56 billion
Estimated Year [2025] USD 7.98 billion
Forecast Year [2032] USD 11.69 billion
CAGR (%) 5.59%

A concise orientation to the strategic intersection of technology, clinical demand, and commercialization that defines modern resuscitation device priorities

Resuscitation devices occupy an essential intersection of emergency medicine, cardiac care and respiratory support, and this executive summary synthesizes the strategic factors shaping innovation, adoption, and procurement. Rapid technological advances, heightened focus on out-of-hospital care, and expanding use cases in both clinical and home environments have elevated the visibility and strategic importance of defibrillators, implantable devices, and wearable therapies. Against this backdrop, stakeholders from product development to hospital procurement must reconcile clinical efficacy, regulatory pathways, reimbursement complexity, and distribution dynamics to remain competitive.

The landscape is characterized by accelerated product iterations, tighter integration with digital health platforms, and increasing emphasis on user-centered design that supports non-clinical responders. Meanwhile, interoperability with electronic health records and telemetry systems is becoming a de facto expectation rather than a differentiator. In this context, decision-makers need clarity on where clinical needs, regulatory constraints, and commercial opportunity converge. This introduction frames the subsequent sections by outlining the emergent trends, tariff-related impacts, segmentation insights, regional dynamics, competitor movements, and recommended actions that together form a practical playbook for leaders in the resuscitation device domain.

How converging advances in miniaturization, connectivity, and care setting shifts are redefining product design priorities and competitive advantage for resuscitation devices

The resuscitation device landscape is undergoing transformative shifts driven by technological innovation, expanded care settings, and evolving clinical protocols. First, miniaturization and power-efficiency gains have enabled more portable and user-friendly external devices while innovations in lead design and battery chemistry are extending the longevity and reliability of implantable systems. Concurrently, algorithmic advances in arrhythmia detection and adaptive pacing logic have improved clinical accuracy, reducing unnecessary interventions and enhancing patient safety.

Second, the expansion of care beyond tertiary hospitals into ambulatory care centers, homecare settings and community public spaces has reshaped product requirements. Resuscitation solutions must now balance clinical-grade performance with simplicity of operation, remote monitoring capability, and cost-effective maintenance. Third, software and connectivity have become central to device value propositions; cloud-enabled event reporting, remote diagnostics and device management platforms are integral to lifecycle support and post-market surveillance. Finally, regulatory agencies are increasingly focused on cybersecurity, software validation, and real-world performance data, which together demand cross-functional alignment between engineering, clinical, and regulatory teams. As a result, companies that integrate clinical evidence generation, digital services and flexible go-to-market models will gain sustainable competitive advantages.

Strategic supply chain reconfiguration and procurement adaptations prompted by tariff interventions that reshaped cost structures and sourcing strategies

The implementation of United States tariffs in 2025 introduced a set of cost and supply-chain dynamics that require strategic recalibration for manufacturers, distributors and health systems. Tariff-induced input cost increases have intensified scrutiny of sourcing strategies, prompting organizations to re-evaluate supplier relationships, nearshoring options and component-level substitutions that preserve clinical performance while managing cost exposure. In response, some manufacturers accelerated qualification of alternate suppliers, prioritized modular designs that allow localized sourcing, and intensified negotiations tied to longer-term purchase agreements and supply guarantees.

Beyond direct cost impacts, tariffs affected inventory planning and lead-time management, pushing procurement teams to adopt more sophisticated demand-forecasting practices and safety-stock strategies. This shift led to increased collaboration between sales and operations teams to align contract terms with production realities and to introduce more flexible manufacturing capacity where feasible. Additionally, the tariffs heightened the appeal of value-added services-such as bundled maintenance, extended warranties, and remote monitoring-to offset price sensitivity and preserve margins. Moving forward, resilient supply-chain design and transparent cost communication will be critical for maintaining market access and supporting long-term clinical adoption.

Comprehensive segmentation analysis revealing how device type, clinical application, end-user setting, and sales channel collectively shape product strategies and commercial execution

A nuanced appreciation of market segmentation illuminates distinct development pathways and commercialization strategies across device types, clinical applications, end users and sales channels. Based on device type, the competitive arena encompasses Automated External Defibrillators, Implantable Cardioverter Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators; within that scope, Automated External Defibrillators are subdivided into Fully Automatic and Semi Automatic variants, Implantable Cardioverter Defibrillators include Biventricular, Dual Chamber and Single Chamber configurations, and Manual External Defibrillators appear in Portable and Stationary formats. These distinctions influence product design priorities, regulatory evidence needs, and post-market support models, with implantable technologies demanding long-term clinical data and external devices focusing on ease of use and maintenance.

Based on application, clinical use cases center on Cardiac Arrest and Respiratory Failure; Cardiac Arrest management includes modalities such as Cardiac Pacing, Cardioversion and Defibrillation, whereas Respiratory Failure care spans Invasive Ventilation, Manual Resuscitation and Non Invasive Ventilation. These application-based differences drive device feature sets, integration requirements with airway and monitoring equipment, and training protocols for end users. Based on end user, the landscape spans Ambulatory Care Centers, Emergency Medical Services, Homecare environments, Hospitals and Specialty Clinics, each of which has distinct procurement cycles, clinical competencies and service expectations. Finally, based on sales channel, market access is achieved through Direct Sales, Distributors and Online Sales strategies, each requiring tailored commercial approaches from field-based clinical engagement to digital marketing and logistics optimization. Understanding the interplay among these segmentation dimensions enables targeted product roadmaps, differentiated value propositions and channel-specific commercial tactics that resonate with clinical and operational buyers.

Regional decision drivers and market access dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption and commercialization strategies

Regional dynamics exert a powerful influence on regulatory timelines, reimbursement mechanisms, and adoption velocities for resuscitation devices. In the Americas, healthcare systems demonstrate a heterogeneous mix of private and public procurement behaviors, where reimbursement clarity and emergency medical services integration are key determinants of adoption. Market participants must align clinical evidence generation and health economics messaging to the priorities of payers and hospital networks in order to drive procurement and deployment decisions.

In Europe, Middle East & Africa, regulatory harmonization efforts and regional procurement consortia create both opportunities and complexities; manufacturers need differentiated regulatory strategies that respect local conformity assessment processes and emerging digital health requirements. In many markets across this region, public tenders and centralized purchasing platforms make pricing transparency and long-term service commitments decisive factors in vendor selection. In the Asia-Pacific region, rapid infrastructure investments, growing chronic disease burdens and expanding primary care capacity accelerate demand for both acute and ambulatory resuscitation solutions. However, market entry often requires careful navigation of local distribution partnerships, product localization, and country-specific regulatory and reimbursement pathways. By aligning commercial models with regional decision drivers, companies can prioritize market entry sequencing and resource allocation to maximize impact.

An overview of competitor strategies, collaborative evidence generation, and capability acquisition trends that define competitive advantage in resuscitation technologies

Competitive dynamics in the resuscitation device space are characterized by a mix of established medical device manufacturers and emerging technology-focused entrants, each pursuing differentiated strategies across product innovation, clinical partnerships and service models. Incumbent manufacturers continue to invest in incremental improvements to implantable lead systems, energy delivery optimization and device longevity, leveraging robust clinical trial data and established distribution networks to defend market share. At the same time, newer entrants emphasize software-enabled diagnostics, machine-learning driven arrhythmia detection and cloud-based device management to create adjacent revenue streams and enhance post-market surveillance.

Collaborations between device developers and large health systems or emergency medical services organizations are increasingly common, enabling real-world evidence generation and accelerated product refinement. Moreover, strategic acquisitions and licensing arrangements remain key mechanisms for companies seeking rapid capability enhancement in digital health, battery technology or telemetry. Amid these trends, successful players demonstrate strong cross-functional coordination between R&D, clinical affairs and commercial teams to shorten feedback loops and ensure that product enhancements map directly to demonstrable clinical or operational benefits. The competitive landscape thus rewards organizations that can couple clinical credibility with agile product development and scalable service delivery.

Actionable commercial, regulatory, and operational priorities that industry leaders should implement to secure resilience, growth, and adoption in resuscitation device markets

Industry leaders should prioritize a set of practical actions to capitalize on demand shifts and technological advances while mitigating regulatory and supply-chain risks. First, align product roadmaps with clinical workflows by validating features through clinician advisory panels and pragmatic, real-world evaluations. This ensures that design choices address frontline usability and translate to measurable improvements in response times and patient outcomes. Second, invest in modular architectures and supplier diversification to reduce single-source dependency and enable rapid component substitution when supply chain disruptions occur. Third, develop integrated digital services that complement device sales, such as remote monitoring, training platforms and outcome analytics, which can strengthen customer retention and create recurring revenue.

Fourth, adopt flexible commercial models that combine direct field engagement for high-acuity settings with distributor partnerships and e-commerce strategies for broader reach and cost efficiency. Fifth, proactively engage regulatory authorities on software and cybersecurity expectations to preempt compliance bottlenecks and accelerate approvals. Finally, build cross-functional go-to-market playbooks that link clinical evidence generation, health economics messaging and procurement value propositions to reduce sales cycles and improve win rates. By implementing these actions in a coordinated manner, organizations can improve resilience, accelerate adoption and sustain profitable growth.

A transparent multi-method research approach combining clinician engagement, regulatory review, and cross-validated secondary analysis to support actionable strategic recommendations

This research synthesis is grounded in a multi-method approach that combines primary stakeholder engagement, secondary literature synthesis and systematic policy review to ensure robust, actionable insights. Primary inputs were gathered through structured interviews with clinicians, procurement decision-makers, and device engineers to capture frontline perspectives on device performance, usability challenges and procurement constraints. These qualitative engagements were complemented by targeted consultations with regulatory specialists to interpret evolving guidance on software, cybersecurity, and post-market surveillance requirements.

Secondary sources were analyzed to contextualize technology trends, clinical practice updates and supply-chain developments. In addition, a cross-validation process reconciled primary insights with publicly available regulatory documents, clinical guidelines and device labelling to ensure factual consistency. Throughout the methodology, emphasis was placed on triangulation-validating findings across multiple independent sources-and on transparency regarding assumptions and limitations. This approach yields an analytical foundation that balances practical relevance with rigorous scrutiny, enabling confident recommendations for product development, market access, and commercial strategy.

Summative implications and strategic priorities that synthesize clinical, commercial, and operational considerations to guide leadership decisions in resuscitation devices

In conclusion, the resuscitation device domain is at an inflection point where product innovation, digital integration and supply-chain resilience collectively determine competitive outcomes. Advances in device algorithms, connectivity and form factor are making it possible to deliver clinical-grade performance in a wider range of care settings, while tariff and procurement pressures are sharpening the need for cost-effective, flexible manufacturing and distribution strategies. Regional nuances in regulatory expectations and health-system procurement practices require tailored market entry and evidence generation plans to ensure successful commercialization.

Decision-makers should therefore pursue integrated strategies that combine rigorous clinical validation, adaptable supply-chain architectures, and differentiated service offerings to create defensible market positions. Cross-functional alignment between engineering, clinical affairs and commercial teams is essential to translate technical capabilities into valued clinical outcomes and compelling procurement propositions. By focusing on these priorities and by engaging early with key stakeholders, organizations can accelerate adoption, mitigate risk and position themselves for sustained impact in the evolving resuscitation device landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-powered predictive analytics in AEDs for proactive cardiac event detection
  • 5.2. Advancements in portable extracorporeal membrane oxygenation devices for field resuscitation support
  • 5.3. Surge in adoption of battery-free CPR assist devices harnessing kinetic energy for emergency scenarios
  • 5.4. Emergence of cloud-connected defibrillator fleets enabling centralized performance analytics and maintenance alerts
  • 5.5. Integration of real-time telemedicine links in automated resuscitation units to support remote clinical guidance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Resuscitation Devices Market, by Device Type

  • 8.1. Automated External Defibrillators
    • 8.1.1. Fully Automatic
    • 8.1.2. Semi Automatic
  • 8.2. Implantable Cardioverter Defibrillators
    • 8.2.1. Biventricular
    • 8.2.2. Dual Chamber
    • 8.2.3. Single Chamber
  • 8.3. Manual External Defibrillators
    • 8.3.1. Portable
    • 8.3.2. Stationary
  • 8.4. Wearable Cardioverter Defibrillators

9. Resuscitation Devices Market, by Application

  • 9.1. Cardiac Arrest
    • 9.1.1. Cardiac Pacing
    • 9.1.2. Cardioversion
    • 9.1.3. Defibrillation
  • 9.2. Respiratory Failure
    • 9.2.1. Invasive Ventilation
    • 9.2.2. Manual Resuscitation
    • 9.2.3. Non Invasive Ventilation

10. Resuscitation Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Emergency Medical Services
  • 10.3. Homecare
  • 10.4. Hospitals
  • 10.5. Specialty Clinics

11. Resuscitation Devices Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Sales

12. Resuscitation Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Resuscitation Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Resuscitation Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Koninklijke Philips N.V.
    • 15.3.2. Medtronic plc
    • 15.3.3. ZOLL Medical Corporation
    • 15.3.4. Nihon Kohden Corporation
    • 15.3.5. Dragerwerk AG & Co. KGaA
    • 15.3.6. Ambu A/S
    • 15.3.7. Becton, Dickinson and Company
    • 15.3.8. Teleflex Incorporated
    • 15.3.9. Smiths Group plc
    • 15.3.10. Mindray Medical International Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESUSCITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. RESUSCITATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. RESUSCITATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. RESUSCITATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RESUSCITATION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL RESUSCITATION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)

TABLE